Minor orthopedic implants include implants used in shoulder, wrist, ankle and foot joints. These implants are used to restore joint function (movement), and relieve pain. Recently, small bone plating, especially in the distal radius segment, has been a positive trend. There is also an increasing trend toward new shoulder prostheses and total ankle replacements. For example, 100,000 shoulder arthroplasties were performed in 2016 in the US, compared to only 14,000 in 2000. This rapid rate of growth is largely due to the increasing popularity of and expanding indications for minor joint procedures, and the size of the aging population that desires to remain active.

The procedure numbers for reverse shoulder arthroplasty are also continuously increasing. Approximately 50% of shoulder replacements in the US, and 70% of shoulder replacements in Europe are reverse shoulder replacement surgery. The balance of shoulder replacements are total shoulder arthroplasty or hemi-arthroplasty. This increased inclination towards reverse shoulder arthroplasties are due to their increasing utilization to treat shoulder fracture patients, expanding applications to both elderly and more active patients, the highly successful outcomes of the procedure, and surgeons becoming more comfortable with the procedure.

The global minor orthopedic replacement implants market is expected to grow from $1,763 million in 2018 to $2,150.4 million in 2021 at an annual growth rate of nearly 7%. Driving the market is the continuously increasing global arthritis population. For example, in the USA, the arthritis population of 54.4 million adults in 2013-15 is expected to increase to 78.4 million by 2040. Of these 78.4 million adults, 34.6 million adults will report arthritis-based activity limitations.

Older people in the USA with advanced stage arthritis are opting for joint replacement surgery to alleviate the pain, and to restore the joint movement. This high prevalence of arthritis is expected to drive the minor orthopedic implants market.

Big orthopedic implant manufacturers such as Depuy Synthes, Zimmer and Biomet, Wright Medical Group, Stryker, Smith & Nephew, etc. are shifting their focus to emerging markets. The BRICs countries are faster growing economies than the US, and represent around 41% of total world population. Due to converging uncertainty about regulatory, economic, and reimbursement trends in the US market, the big orthopedic device companies (Stryker, J&J/DePuy/Synthes, Zimmer/Biomet, Smith & Nephew and Medtronic Spine) are shifting their resources, training, inventories, clinical studies, and R&D efforts to these big four emerging orthopedic markets.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.